Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants

The coronavirus disease-19 (COVID-19) pandemic has been ongoing since December 2019, with more than 6.3 million deaths reported globally as of August 2022. Despite the success of several SARS-CoV-2 vaccines, the rise in variants, some of which are resistant to the effects of vaccination, highlights...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liqing, Qi, Xiaoxiao, Liang, Dan, Li, Guiqi, Peng, Xiaofang, Li, Xiaohui, Ke, Bixia, Zheng, Huanying, Liu, Zhongqiu, Ke, Changwen, Liao, Guochao, Liu, Liang, Feng, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505662/
https://www.ncbi.nlm.nih.gov/pubmed/36146579
http://dx.doi.org/10.3390/vaccines10091502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505662/
https://www.ncbi.nlm.nih.gov/pubmed/36146579
http://dx.doi.org/10.3390/vaccines10091502

Ejemplares similares